These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 18619669)

  • 1. Progress in matrix metalloproteinase research.
    Murphy G; Nagase H
    Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases.
    Zitka O; Kukacka J; Krizkova S; Huska D; Adam V; Masarik M; Prusa R; Kizek R
    Curr Med Chem; 2010; 17(31):3751-68. PubMed ID: 20846107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metalloproteinases. Structure and function].
    Lipka D; Boratyński J
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():328-36. PubMed ID: 18614970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases in tumor invasion.
    Johansson N; Ahonen M; Kähäri VM
    Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.
    Aureli L; Gioia M; Cerbara I; Monaco S; Fasciglione GF; Marini S; Ascenzi P; Topai A; Coletta M
    Curr Med Chem; 2008; 15(22):2192-222. PubMed ID: 18781944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of matrix metalloproteinases in normal and disease processes.
    McDonnell S; Morgan M; Lynch C
    Biochem Soc Trans; 1999 Aug; 27(4):734-40. PubMed ID: 10917674
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural studies on MMPs and TIMPs.
    Bode W; Maskos K
    Methods Mol Biol; 2001; 151():45-77. PubMed ID: 11217319
    [No Abstract]   [Full Text] [Related]  

  • 11. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of the inhibition of matrix metalloproteinases by tissue inhibitor of metalloproteinases (TIMP).
    Hutton M; Willenbrock F
    Methods Mol Biol; 2001; 151():519-32. PubMed ID: 11217325
    [No Abstract]   [Full Text] [Related]  

  • 14. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of human and mouse matrix metalloproteinase families.
    Jackson BC; Nebert DW; Vasiliou V
    Hum Genomics; 2010 Feb; 4(3):194-201. PubMed ID: 20368140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors.
    Fata JE; Ho AT; Leco KJ; Moorehead RA; Khokha R
    Cell Mol Life Sci; 2000 Jan; 57(1):77-95. PubMed ID: 10949582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis.
    Khasigov PZ; Podobed OV; Gracheva TS; Salbiev KD; Grachev SV; Berezov TT
    Biochemistry (Mosc); 2003 Jul; 68(7):711-7. PubMed ID: 12946252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for Analysis of Matrix Degradation by CCN2 Through the MMP/TIMP System.
    McLennan SV; Min D; Wang X; Twigg SM
    Methods Mol Biol; 2017; 1489():523-532. PubMed ID: 27734403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RECK, a novel matrix metalloproteinase regulator.
    Meng N; Li Y; Zhang H; Sun XF
    Histol Histopathol; 2008 Aug; 23(8):1003-10. PubMed ID: 18498076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.